Abstract
to assess quality of life, anxiety and depression in patients with Chronic Obstructive Pulmonary Disease. a cross-sectional, quantitative study, conducted in a reference hospital for the treatment of pulmonary diseases. Seventy patients were assessed, using a sociodemographic and clinical questionnaire, Beck's anxiety and Depression Inventories and the SF-36 Quality of Life Scale. the participants had better quality of life in the vitality, mental health and social role functioning domains (median=50.0) and worse in limitation by physical and emotional role functioning (median=0.0 points). Anxiety, depression and oxygen dependence were associated with poorer results in the quality of life domains. all patients were classified with severe anxiety level and moderate depression predominance. Patients had low quality of life scores in all domains.
Highlights
METHODSChronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable respiratory disease
There was a predominance of male patients, older adults, retired or those with a social benefit, married, with elementary or high school education, Catholic or Physical functioning Physical role functioning Bodily pain General health perceptions Vitality Social role functioning Emotional role functioning Mental health ρ = -0.478; p < 0.0011 ρ = -0.021; p = 0.864 ρ = -0.362; p = 0.0021 ρ = -0.195; p = 0.105 ρ = -0.250; p = 0.0371 ρ = -0.533; p < 0.0011 ρ = -0.011; p = 0.930 ρ = -0.308; p = 0.0091
Physical role functioning and Emotional role functioning were those with the lowest scores, with Physical and Emotional role functioning scoring zero points
Summary
Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable respiratory disease. It is characterized by incapacitating the body to perform adequate gas exchange, which results in progressive dyspnea, either with or without associated secretion, which can compromise the performance of daily activities[1]. The populational ageing, associated with smoking, is estimated to increase the prevalence and deaths by the disease. In a study that analyzed the trends in standardized mortality rates due to diseases attributable to tobacco, a one-third decrease in deaths due to COPD was identified; this rate has shown a new trend of increase in the last three years of the series. Mortality from COPD is still the leading cause of tobacco-related death[3]. In addition to individual impacts, such as decreased quality of life, the disease is responsible for increased health care costs because patients experience recurrent exacerbations resulting in more frequent hospitalizations as the disease progresses[1]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
